Literature DB >> 6802479

Sodium valproate and thrombocytopenia.

L M Hoffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802479      PMCID: PMC1862880     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  IgM platelet autoantibody due to sodium valproate.

Authors:  R M Sandler; C Emberson; G E Roberts; D Voak; J Darnborough; A F Heeley
Journal:  Br Med J       Date:  1978-12-16

2.  Thrombocytopenia associated with sodium valproate treatment.

Authors:  A N Neophytides; J G Nutt; J R Lodish
Journal:  Ann Neurol       Date:  1979-04       Impact factor: 10.422

3.  Sodium valproate and thrombocytopenia.

Authors:  D A Winfield; P Benton; M L Espir; L J Arthur
Journal:  Br Med J       Date:  1976-10-23

4.  Valproic acid and thrombocytopenia.

Authors:  N Morris; R D Barr; K R Pai; J G Kelton
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

5.  Valproic acid (Depakene). A new anticonvulsant agent.

Authors:  J R Lewis
Journal:  JAMA       Date:  1978-11-10       Impact factor: 56.272

  5 in total
  2 in total

Review 1.  Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.

Authors:  Rosanne W Meijboom; Koen P Grootens
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

2.  Haematological disturbances during long-term valproate therapy.

Authors:  B Brichard; C Vermylen; J M Scheiff; J Ninane; G Cornu
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.